Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B

Liver Transplantation

Volumn 15, Issue 9, 2009, Pages 1010-1020

  Bzowej, Natalie ^a   Han, Steven ^b   Degertekin, Bulent ^c   Keeffe, Emmet B ^d   Emre, Sukru ^e,h   Brown, Robert ^f   Reddy, Rajender ^g   Lok, Anna S ^c  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MOUNT SINAI MEDICAL CENTER   (United States)

^f Center for Liver Disease and Transplantation Columbia University College of Physicians and Surgeons ^*  (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B ANTIBODY;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN AMERICAN; CAUCASIAN; CONTROLLED STUDY; DEATH; FEMALE; HEPATITIS B; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROBABILITY; RECURRENT INFECTION; TREATMENT OUTCOME; UNITED STATES;

ADULT; AFRICAN AMERICANS; ASIAN AMERICANS; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VIRAL LOAD; WAITING LISTS;

EID: 70350523346     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21759     Document Type: Article

References (27)

1. Moore DE, Feurer ID, Rodgers S Jr, Shaffer D, Nylander W, Gorden DL, et al. Is there racial disparity in outcomes after solid organ transplantation? Am J Surg 2004;188:571-574.
2. Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet 2002;359:287-293. (Pubitemid 34119291)
3. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004;10:886-897. (Pubitemid 38979259)
4. Lee TH, Shah N, Pedersen RA, Kremers WK, Rosen CB, Klintmalm GB, et al. Survival after liver transplantation: is racial disparity inevitable? Hepatology 2007;46:1491-1497.
5. Jacobs JM, Martin P, Munoz SJ, Westerberg S, Hann HW, Moritz MJ, et al. Liver transplantation for chronic hepatitis B in Asian males. Transplant Proc 1993;25:1904-1906. (Pubitemid 23125142)
6. Jurim O, Martin P, Shaked A, Goldstein L, Millis JM, Calquhoun SD, et al. Liver transplantation for chronic hepatitis B in Asians. Transplantation 1994;57:1393-1395. (Pubitemid 24145589)
7. Ho BM, So SK, Esquivel CO, Keeffe EB. Liver transplantation in Asian patients with chronic hepatitis B. Hepatology 1997;25:223-225. (Pubitemid 27015014)
8. Teo EK, Han SH, Terrault N, Luketic V, Jensen D, Keeffe EB, et al. Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients. Hepatology 2001;34:126-132. (Pubitemid 32591492)
9. Kim WR, Poterucha JJ, Kremers WK, Ishitani MB, Dickson ER. Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl 2004;10:968-974. (Pubitemid 39232749)
10. Wong SN, Reddy KR, Keeffe EB, Han SH, Gaglio PJ, Perrillo RP, et al. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma. Liver Transpl 2007;13:334-342. (Pubitemid 46444461)
11. Tan J, Degertekin B, Wong SN, Husain M, Oberhelman K, Lok AS. Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations. J Hepatol 2008;48:391-398.
12. Degertekin B, Hussain M, Tan J, Oberhelman K, Lok AS. Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance. J Hepatol 2009;50:42-48.
13. Screening for chronic hepatitis B among Asian/Pacific Islander populations - New York City, 2005. MMWR Morb Mortal Wkly Rep 2006;55:505-509.
14. Guane R, Siu P, Lam K, Kim KE, Warren V, Liu H, et al. Prevalence of HBV and risk of HBV acquisition in hepatitis B screening programs in large metropolitan cities in the United States. Hepatology 2004;40:716A.
15. Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology 2007;46:1034-1040.
16. McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999;89:14-18.
17. Epstein AM, Ayanian JZ, Keogh JH, Noonan SJ, Armistead N, Cleary PD, et al. Racial disparities in access to renal transplantation - clinically appropriate or due to underuse or overuse? N Engl J Med 2000;343:1537-1544.
18. Sumi H, Yokosuka O, Seki N, Arai M, Imazeki F, Kurihara T, et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 2003;37:19-26. (Pubitemid 36042140)
19. Yuen MF, Sablon E, Yuan HJ, Wong DK, Hui CK, Wong BC, et al. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma. Hepatology 2003;37:562-567. (Pubitemid 36258778)
20. Chan HL, Hui AY, Wong ML, Tse AM, Hung LC, Wong VW, et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 2004;53:1494-1498. (Pubitemid 39265273)
21. Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 2005;97:265-272.
22. Gaglio P, Singh S, Degertekin B, Ishitani M, Hussain M, Perrillo R, et al. Impact of the hepatitis B virus genotype on pre- and post-liver transplantation outcomes. Liver Transpl 2008;14:1420-1427.
23. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002;347:168-174. (Pubitemid 34764820)
24. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65-73. (Pubitemid 43042691)
25. Kasiske BL, Neylan JF III, Riggio RR, Danovitch GM, Kahana L, Alexander SR, et al. The effect of race on access and outcome in transplantation. N Engl J Med 1991;324:302-307.
26. Eckhoff DE, McGuire BM, Young CJ, Sellers MT, Frenette LR, Hudson SL, et al. Race: a critical factor in organ donation, patient referral and selection, and orthotopic liver transplantation? Liver Transpl Surg 1998;4:499-505.
27. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699. (Pubitemid 26079803)